Campbell & Co Investment Adviser’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84.9K Buy
+17,223
New +$92.4K ﹤0.01% 1001
2020
Q1
Sell
-7,874
Closed -$236K 68
2019
Q4
$236K Buy
+7,874
New +$205K 0.07% 514
2015
Q3
Sell
-4,200
Closed -$933K 324
2015
Q2
$933K Buy
+4,200
New +$931K 0.8% 50
2014
Q2
Sell
-26,330
Closed -$3.47M 162
2014
Q1
$3.47M Buy
+26,330
New +$3.6M 1.4% 18
2013
Q3
Sell
-3,550
Closed -$306K 243
2013
Q2
$306K Buy
+3,550
New +$280K 0.06% 259

Other funds holding BHC

Campbell & Co Investment Adviser's BHC Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Bausch Health (BHC) in Q2 2026: 17,223 shares worth $84.9K. The stake represents ﹤0.01% of the portfolio and ranks #1001 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in BHC as recently as Q4 2019.

Campbell & Co Investment Adviser first reported a position in BHC in Q2 2013 and has held it in 5 quarters since. The position peaked at $3.47M in Q1 2014. 221 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Campbell & Co Investment Adviser held 17,223 shares of Bausch Health worth $84.9K as of Q2 2026.
  • Bausch Health was a new Campbell & Co Investment Adviser position in Q2 2026.
  • Bausch Health made up ﹤0.01% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #1001 holding.
  • Campbell & Co Investment Adviser first reported a position in Bausch Health in Q2 2013 and has held it in 5 quarters since.
  • Campbell & Co Investment Adviser's Bausch Health position peaked at $3.47M in Q1 2014.
  • 221 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.